Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | 5-hydroxytryptamine receptor 2A | ||
Ligand | BDBM50301516 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_600346 (CHEMBL1041064) | ||
Ki | 0.61±n/a nM | ||
Citation | Dosa, PI; Strah-Pleynet, S; Jayakumar, H; Casper, M; Decaire, M; Xiong, Y; Lehmann, J; Choi, K; Elwell, K; Wong, A; Webb, RR; Adams, JW; Ramirez, J; Richman, JG; Thomsen, W; Semple, G; Teegarden, BR Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agents. Bioorg Med Chem Lett19:5486-9 (2009) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
5-hydroxytryptamine receptor 2A | |||
Name: | 5-hydroxytryptamine receptor 2A | ||
Synonyms: | 5-HT-2 | 5-HT-2A | 5-HT2A | 5-hydroxytryptamine receptor 2A (5-HT-2A) | 5-hydroxytryptamine receptor 2A (5HT-2A) | 5-hydroxytryptamine receptor 2A (5HT2A) | 5HT2A_HUMAN | HTR2 | HTR2A | Serotonin receptor 2A | ||
Type: | undefined | ||
Mol. Mass.: | 52607.65 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P28223 | ||
Residue: | 471 | ||
Sequence: |
| ||
BDBM50301516 | |||
n/a | |||
Name | BDBM50301516 | ||
Synonyms: | 1-(3-(4-chloro-1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)-3-(4-chlorophenyl)urea | CHEMBL568313 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H25Cl2N5O3 | ||
Mol. Mass. | 490.382 | ||
SMILES | Cn1ncc(Cl)c1-c1cc(NC(=O)Nc2ccc(Cl)cc2)ccc1OCCN1CCOCC1 |(29.57,-25.86,;29.54,-27.4,;30.77,-28.33,;30.26,-29.79,;28.72,-29.75,;27.78,-30.98,;28.28,-28.28,;26.83,-27.76,;25.5,-28.53,;24.16,-27.76,;22.83,-28.53,;21.5,-27.77,;21.49,-26.23,;20.16,-28.54,;18.83,-27.77,;17.49,-28.54,;16.16,-27.77,;16.16,-26.23,;14.83,-25.46,;17.49,-25.46,;18.82,-26.22,;24.16,-26.23,;25.48,-25.45,;26.83,-26.22,;28.16,-25.45,;28.15,-23.91,;29.48,-23.13,;30.82,-23.9,;30.82,-25.44,;32.15,-26.2,;33.48,-25.43,;33.48,-23.89,;32.14,-23.12,)| | ||
Structure |